An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteriemia in hematology patients

Haematologica

Volumn 91, Issue 8, 2006, Pages 1134-1138

  Micol, Jean Baptiste ^a   De Botton, Stéphane ^a   Guieze, Romain ^a   Coiteux, Valérie ^a   Darre, Stéphane ^a   Dessein, Rodrigue ^a   Leroy, Olivier ^b   Yakoub Agha, Ibrahim ^a   Quesnel, Bruno ^a   Bauters, Francis ^a   Beaucaire, Gilles ^a   Alfandari, Serge ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Service de Reanimation et Maladies Infectieuses   (France)

Author keywords

Bacteriemia; Colistin; Hematologic malignancy; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; TICARCILLIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; CLINICAL ARTICLE; DEATH; DRUG SENSITIVITY; DRUG TOLERANCE; EPIDEMIC; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION CONTROL; MALE; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; HEMATOLOGIC NEOPLASMS; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33747010662     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa. Microb Drug Resist. 2005;11:68-74.
2. Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 2003;37:e154-60.
3. Todeschini G, Franchini M, Tecchio C, Meneghini V, Pizzolo G, Veneri D, et al. Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies. Int J Infect Dis 1998;3:99-104.
4. Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes. Arch Intern Med 2000;160: 501-9.
5. Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 2005;49: 3136-46.
6. Richet H, Escande MC, Marie JP, Zittoun R, Lagrange PH. Epidemic Pseudomonas aeruginosa serotype O16 bacteremia in hematology-oncology patients. J Clin Microbiol 1989;27: 1992-6.
7. Engelhart S, Krizek L, Glasmacher A, Fischnaller E, Marklein G, Exner M. Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect 2002;52:93-8.
8. Lyytikainen O, Golovanova V, Kolho E, Ruutu P, Sivonen A, Tiittanen L. Outbreak caused by tobramycin-resistant Pseudomonas aeruginosa in a bone marrow transplantation unit. Scand J Infect Dis 2001;33:445-9.
9. Verweij PE, Bijl D, Melchers WJ, De Pauw BE, Meis JF, Hooskamp-Korstanje JA, et al. Pseudo-outbreak of multiresistant Pseudomonas aeruginosa in a hematology unit. Infect Control Hosp Epidemiol 1997;18:128-31.
10. Gillespie TA, Johnson PR, Notman AW, Coia JE, Hanson MF. Eradication of a resistant Pseudomonas aeruginosa strain after a cluster of infections in a hematology/oncology unit. Clin Microbiol Infect 2000;6:125-30.
11. Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003;37:745-51.
12. Vidal F, Mensa J, Almela M, Martinez JA, Marco F, Casals C, et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med 1996;156:2121-6.
13. Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis. 2004;4:519-27.
14. Paul M, Leibovici L. Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia. Lancet Infect Dis. 2005;5:192-3.
15. Song W, Woo HJ, Kim JS, Lee KM. In vitro activity of β-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa. Int J Antimicrob Agents 2003;21:8-12.
16. Oie S, Uematsu T, Sawa A, Mizuno H, Tomita M, Ishida S, et al. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother 2003; 52:911-4.
17. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-41.
18. Beno P, Krcmery V, Demitrovicova A. Bacteraemia in cancer patients causes by colistin-resistant Gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin. Clin Microbiol Infect 2006;12:497-8.
19. Ohmagari N, Hanna H, Graviss L, Hackett B, Perego C, Gonzalez V, et al. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer. 2005;104:205-12.
20. El Amari EB, Chamot E, Auckenthaler R, Pechere JC, Van Delden C. Influence or previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis 2001;33:1859-64.